{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:01:44Z","timestamp":1761102104338},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,2,10]],"date-time":"2014-02-10T00:00:00Z","timestamp":1391990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,2,10]],"date-time":"2014-02-10T00:00:00Z","timestamp":1391990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1038\/bmt.2014.4","type":"journal-article","created":{"date-parts":[[2014,2,10]],"date-time":"2014-02-10T11:44:30Z","timestamp":1392032670000},"page":"671-678","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphoma"],"prefix":"10.1038","volume":"49","author":[{"given":"I","family":"Avivi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Canals","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J-P","family":"Vernant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Wulf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Nagler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Yakoub-Agha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Craddock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Schattenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Niederwieser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Blaise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Attal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Pfreundschuh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Passweg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Dreger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Sureda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the EBMT Lymphoma Working Party","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,10]]},"reference":[{"key":"BFbmt20144_CR1","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1182\/blood.V92.2.405","volume":"92","author":"J Blay","year":"1998","unstructured":"Blay J, Gomez F, Sebban C, Bachelot T, Biron P, Guglielmi C et al. The International Prognostic Index correlates to survival in patients with aggressive lymphoma in relapse: analysis of the PARMA trial. Parma Group. Blood 1998; 92: 3562\u20133568.","journal-title":"Blood"},{"key":"BFbmt20144_CR2","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.1200\/JCO.2010.28.1618","volume":"28","author":"C Gisselbrecht","year":"2010","unstructured":"Gisselbrecht C, Glass B, Mounier N, Singh Gill D, Linch DC, Trneny M et al. Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era. J Clin Oncol 2010; 28: 4184\u20134190.","journal-title":"J Clin Oncol"},{"key":"BFbmt20144_CR3","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1200\/JCO.2010.30.2596","volume":"29","author":"RJ van Kampen","year":"2011","unstructured":"van Kampen RJ, Canals C, Schouten HC, Nagler A, Thomson KJ, Vernant JP et al. Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem-cell transplantation: an analysis of the European Group for Blood and Marrow Transplantation Registry. J Clin Oncol 2011; 29: 1342\u20131348.","journal-title":"J Clin Oncol"},{"key":"BFbmt20144_CR4","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1365-2141.2011.08818.x","volume":"156","author":"S Moore","year":"2012","unstructured":"Moore S, Peggs K, Thomson K, Lowry L, Ljubic A, Goldstone AH et al. Autologous stem cell transplantation remains beneficial for patients relapsing after R-CHOP chemotherapy and who respond to salvage chemotherapy. Br J Haematol 2012; 156: 142\u2013143.","journal-title":"Br J Haematol"},{"key":"BFbmt20144_CR5","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1182\/asheducation-2011.1.498","volume":"2011","author":"JW Friedberg","year":"2011","unstructured":"Friedberg JW . Relapsed\/refractory diffuse large B-cell lymphoma. Hematology Am Soc Hematol Educ Program 2011; 2011: 498\u2013505.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"BFbmt20144_CR6","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1200\/JCO.2008.17.3328","volume":"27","author":"KJ Thomson","year":"2009","unstructured":"Thomson KJ, Morris EC, Bloor A, Cook G, Milligan D, Parker A et al. Favorable long-term survival after reduced-intensity allogeneic transplantation for multiple-relapse aggressive non-Hodgkin's lymphoma. J Clin Oncol 2009; 27: 426\u2013432.","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"BFbmt20144_CR7","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1038\/bmt.2008.110","volume":"42","author":"D Maloney","year":"2008","unstructured":"Maloney D . Allogeneic transplantation following nonmyeloablative conditioning for aggressive lymphoma. Bone Marrow Transplant 2008; 42 (Suppl 1): S35\u2013S36.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt20144_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.bbmt.2009.09.002","volume":"16","author":"A Sirvent","year":"2010","unstructured":"Sirvent A, Dhedin N, Michallet M, Mounier N, Faucher C, Yakoub-Agha I et al. Low nonrelapse mortality and prolonged long-term survival after reduced-intensity allogeneic stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma: report of the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire. Biol Blood Marrow Transplant 2010; 16: 78\u201385.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt20144_CR9","doi-asserted-by":"publisher","first-page":"4310","DOI":"10.1182\/blood-2001-11-0107","volume":"100","author":"SP Robinson","year":"2002","unstructured":"Robinson SP, Goldstone AH, Mackinnon S, Carella A, Russell N, de Elvira CR et al. Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation. Blood 2002; 100: 4310\u20134316.","journal-title":"Blood"},{"key":"BFbmt20144_CR10","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1365-2141.2008.07365.x","volume":"143","author":"AR Rezvani","year":"2008","unstructured":"Rezvani AR, Norasetthada L, Gooley T, Sorror M, Bouvier ME, Sahebi F et al. Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience. Br J Haematol 2008; 143: 395\u2013403.","journal-title":"Br J Haematol"},{"key":"BFbmt20144_CR11","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.bbmt.2006.05.018","volume":"12","author":"I Aksentijevich","year":"2006","unstructured":"Aksentijevich I, Jones RJ, Ambinder RF, Garrett-Mayer E, Flinn IW . Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma. Biol Blood Marrow Transplant 2006; 12: 965\u2013972.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt20144_CR12","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/j.bbmt.2006.08.035","volume":"12","author":"R Rodriguez","year":"2006","unstructured":"Rodriguez R, Nademanee A, Ruel N, Smith E, Krishnan A, Popplewell L et al. Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma. Biol Blood Marrow Transplant 2006; 12: 1326\u20131334.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt20144_CR13","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s00277-011-1395-9","volume":"91","author":"L Rigacci","year":"2012","unstructured":"Rigacci L, Puccini B, Dodero A, Iacopino P, Castagna L, Bramanti S et al. Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: A GITMO study. Ann Hematol 2012; 91: 931\u2013939.","journal-title":"Ann Hematol"},{"key":"BFbmt20144_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.bbmt.2009.08.011","volume":"16","author":"HM Lazarus","year":"2010","unstructured":"Lazarus HM, Zhang MJ, Carreras J, Hayes-Lattin BM, Ataergin AS, Bitran JD et al. A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR. Biol Blood Marrow Transplant 2010; 16: 35\u201345.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt20144_CR15","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/sj.bmt.1703891","volume":"31","author":"AJ Peniket","year":"2003","unstructured":"Peniket AJ, Ruiz de Elvira MC, Taghipour G, Cordonnier C, Gluckman E, de Witte T et al. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation. Bone Marrow Transplant 2003; 31: 667\u2013678.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt20144_CR16","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.bbmt.2009.01.010","volume":"15","author":"M Hamadani","year":"2009","unstructured":"Hamadani M, Benson DM Jr, Hofmeister CC, Elder P, Blum W, Porcu P et al. Allogeneic stem cell transplantation for patients with relapsed chemorefractory aggressive non-hodgkin lymphomas. Biol Blood Marrow Transplant 2009; 15: 547\u2013553.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt20144_CR17","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/j.1365-2141.2009.07905.x","volume":"147","author":"I Avivi","year":"2009","unstructured":"Avivi I, Montoto S, Canals C, Maertens J, Al-Ali H, Mufti GJ et al. Matched unrelated donor stem cell transplant in 131 patients with follicular lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. Br J Haematol 2009; 147: 719\u2013728.","journal-title":"Br J Haematol"},{"key":"BFbmt20144_CR18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1365-2141.2005.05755.x","volume":"131","author":"RT Doocey","year":"2005","unstructured":"Doocey RT, Toze CL, Connors JM, Nevill TJ, Gascoyne RD, Barnett MJ et al. Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphoma. Br J Haematol 2005; 131: 223\u2013230.","journal-title":"Br J Haematol"},{"key":"BFbmt20144_CR19","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1093\/annonc\/mdn404","volume":"19","author":"MR Bishop","year":"2008","unstructured":"Bishop MR, Dean RM, Steinberg SM, Odom J, Pavletic SZ, Chow C et al. Clinical evidence of a graft-versus-lymphoma effect against relapsed diffuse large B-cell lymphoma after allogeneic hematopoietic stem-cell transplantation. Ann Oncol 2008; 19: 1935\u20131940.","journal-title":"Ann Oncol"},{"key":"BFbmt20144_CR20","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","volume":"15","author":"A Bacigalupo","year":"2009","unstructured":"Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant 2009; 15: 1628\u20131633.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt20144_CR21","unstructured":"EBMT MED-AB FORMS MANUAL Available at http:\/\/www.ebmt.org\/Contents\/Data-Management\/Registrystructure\/MED-ABdatacollectionforms\/Documents\/MED-ABFormsManual.pdf Accessed in August 2012."},{"key":"BFbmt20144_CR22","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"BD Cheson","year":"1999","unstructured":"Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999; 17: 1244.","journal-title":"J Clin Oncol"},{"key":"BFbmt20144_CR23","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825\u2013828.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt20144_CR24","first-page":"86","volume-title":"The ESH-EBMT Handbook: Hematopoietic Stem Cell Transplantation","author":"E Gluckman","year":"2012","unstructured":"Gluckman E . Choice of the donor according to HLA typing and stem cell source. In: Apperley J, Carreras E, Gluckman E, Masszi T (eds).. The ESH-EBMT Handbook: Hematopoietic Stem Cell Transplantation 6th edn Forum Service Editor, 2012 pp 86\u2013102."},{"key":"BFbmt20144_CR25","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.bbmt.2009.01.012","volume":"15","author":"K van Besien","year":"2009","unstructured":"van Besien K, Carreras J, Bierman PJ, Logan BR, Molina A, King R et al. Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes. Biol Blood Marrow Transplant 2009; 15: 554\u2013563.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt20144_CR26","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/sj.bmt.1705027","volume":"36","author":"E Kusumi","year":"2005","unstructured":"Kusumi E, Kami M, Kanda Y, Murashige N, Kishi Y, Suzuki R et al. Reduced-intensity hematopoietic stem-cell transplantation for malignant lymphoma: a retrospective survey of 112 adult patients in Japan. Bone Marrow Transplant 2005; 36: 205\u2013213.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt20144_CR27","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1182\/blood-2004-03-1105","volume":"104","author":"E Morris","year":"2004","unstructured":"Morris E, Thomson K, Craddock C, Mahendra P, Milligan D, Cook G et al. Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma. Blood 2004; 104: 3865\u20133871.","journal-title":"Blood"},{"key":"BFbmt20144_CR28","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/blood.V77.3.649.649","volume":"77","author":"RJ Jones","year":"1991","unstructured":"Jones RJ, Ambinder RF, Piantadosi S, Santos GW . Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation. Blood 1991; 77: 649\u2013653.","journal-title":"Blood"},{"key":"BFbmt20144_CR29","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.bbmt.2010.10.030","volume":"17","author":"ED Warlick","year":"2011","unstructured":"Warlick ED, Tomblyn M, Cao Q, Defor T, Blazar BR, Macmillan M et al. Reduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive non-Hodgkin lymphomas. Biol Blood Marrow Transplant 2011; 17: 1025\u20131032.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt20144_CR30","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.bbmt.2013.01.024","volume":"19","author":"M Hamadani","year":"2013","unstructured":"Hamadani M, Saber W, Ahn KW, Carreras J, Cairo MS, Fenske TS et al. Impact of pretransplantation conditioning regimens on outcomes of allogeneic transplantation for chemotherapy-unresponsive diffuse large B cell lymphoma and grade III follicular lymphoma. Biol Blood Marrow Transplant 2013; 19: 746\u2013753.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt20144_CR31","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.bbmt.2010.12.702","volume":"17","author":"VT Ho","year":"2011","unstructured":"Ho VT, Kim HT, Aldridge J, Liney D, Kao G, Armand P et al. Use of matched unrelated donors compared with matched related donors is associated with lower relapse and superior progression-free survival after reduced-intensity conditioning hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2011; 17: 1196\u20131204.","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt20144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt20144","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt20144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T18:23:44Z","timestamp":1648059824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt20144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,10]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["BFbmt20144"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2014.4","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"type":"print","value":"0268-3369"},{"type":"electronic","value":"1476-5365"}],"subject":[],"published":{"date-parts":[[2014,2,10]]},"assertion":[{"value":"9 July 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}